Serological and molecular epidemiology of hepatitis D virus: a four-year single-center retrospective analysis
Annals of Clinical and Analytical Medicine · 2026-11-01 · 17 (11) · 1172-1176
DOI: 10.4328/acam.23039 ↗Abstract
Aim To assess the serological and molecular epidemiology of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections by analyzing HBV surface antigen (HBsAg), Anti-HDV, and HDV ribonucleic acid (RNA) test results from May 2021 to May 2025 at Ordu University Training and Research Hospital. Methods This single-center retrospective study used Laboratory Information Management System records. Patients aged 0-100 years with at least one request for an HBsAg, Anti-HDV, or HDV RNA test were included. To minimize duplication, only the earliest record per patient for each marker was analyzed. Positivity rates were summarized descriptively and compared by sex and age using Pearson’s chi-square test. Results Among 316,375 individuals tested for HBsAg, 8,054 (2.5%) were positive. HBsAg positivity was higher in men than in women (P = .0011). Positivity was low among those .05). HDV RNA was requested in 64 patients, and 3 (4.68%) were positive. Conclusion HBsAg positivity suggests an intermediate level of HBV endemicity in our region, whereas Anti-HDV seropositivity appears low. Because Anti-HDV and HDV RNA testing were not systematically performed in all HBsAg-positive individuals, the true burden of HDV infection may be underestimated. Standardized screening strategies among HBsAg-positive patients are warranted to better define regional HDV epidemiology.
EUVIMED